ATarhiniMDPhD· @ATarhiniMDPhD · X·· 3 天前评分60
正文 · 原文
#ESMO26 Abstracts – Among ours | #Realworld stage III #melanoma outcomes following #neoadjuvant #nivolumab + #relatlimab or #nivolumab + #ipilimumab | To be presented by Mike Postow on behalf of this outstanding team in #Madrid #Spain | @MoffittNews https://t.co/s9wp2gDJRD https://t.co/S9w9gnGiQo
热度 6 · 4 赞 · 0 回复 · 2 转发
来源：ATarhiniMDPhD · x.com